Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Dec;34(12):7647-7649.
doi: 10.1007/s00330-024-11071-1. Epub 2024 Sep 12.

Can a comprehensive gadoxetic acid-enhanced MRI with MRCP be used for early diagnosis, monitoring, and outcome prediction of PSC?

Sarah Poetter-Lang  1 , Nina Bastati  1 , Ulrike Attenberger  1 , Emina Halilbasic  2 , Michael Trauner  2 , Ahmed Ba-Ssalamah  3
Affiliations

Can a comprehensive gadoxetic acid-enhanced MRI with MRCP be used for early diagnosis, monitoring, and outcome prediction of PSC?

Sarah Poetter-Lang et al. Eur Radiol. 2024 Dec.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Compliance with ethical standards. Guarantor: The scientific guarantor of this publication is Dr. Ahmed Ba-Ssalamah. Conflict of interest: The authors of this manuscript declare relationships with the following companies: Sarah Poetter-Lang: nothing to disclose. Ahmed Ba-Ssalamah: honoraria for consulting from Bayer, speaker fees from Bayer and Siemens and Sanofi. This has no relation to this publication. Nina Bastati: nothing to disclose. Emina Halilbasic: nothing to disclose. Michael Trauner: received grant support from Albireo, Cymabay, Falk, Gilead, Intercept, MSD, and Takeda; honoraria for consulting from BiomX, Boehringer Ingelheim, Falk, Genfit, Gilead, Intercept, Janssen, MSD, Novartis, Phenex, and Regulus; speaker fees from BMS, Falk, Gilead, Intercept and MSD, as well as travel support from Abbvie, Falk, Gilead and Intercept. Statistics and biometry: NA. Informed consent: Retrospective analysis, Informed Consent waived by IRB. Ethical approval: Institutional Review Board approval was obtained. Ethics Commission (EC), Nr: 2249/2016 Radiologic Diagnosis of Cholestatic Liver Disease; A Retrospective Data Analysis. Study subjects or cohort overlap: NA. Methodology: Letter to the editor

Comment in

References

    1. Poetter-Lang S, Ba-Ssalamah A, Messner A et al (2024) Disease severity prognostication in primary sclerosing cholangitis: a validation of the Anali scores and comparison with the potential functional stricture. Eur Radiol. https://doi.org/10.1007/s00330-024-10787-4
    1. Poetter-Lang S, Messner A, Bastati N et al (2023) Diagnosis of functional strictures in patients with primary sclerosing cholangitis using hepatobiliary contrast-enhanced MRI: a proof-of-concept study. Eur Radiol. https://doi.org/10.1007/s00330-023-09915-3
    1. Bowlus CL, Arrive L, Bergquist A et al (2023) AASLD practice guidance on primary sclerosing cholangitis and cholangiocarcinoma. Hepatology 77:659–702 - DOI - PubMed
    1. European Association for the Study of the Liver (2022) EASL clinical practice guidelines on sclerosing cholangitis. J Hepatol 77:761–806
    1. Venkatesh SK, Welle CL, Miller FH et al (2021) Reporting standards for primary sclerosing cholangitis using MRI and MR cholangiopancreatography: guidelines from MR Working Group of the International Primary Sclerosing Cholangitis Study Group. Eur Radiol. https://doi.org/10.1007/s00330-021-08147-7

LinkOut - more resources